Question about Monday’s PR - it states in the title that the DMC approved increased dosing FREQUENCY. It then states in the body that dosing DURATION was increased from 3 to 5 days, but mentions nothing further about frequency, which would be something like moving from a daily dose to BID for example. Do we think that frequency was also increased as well as duration? Or is it more likely the wrong term was used in the title?
Speaking of dosing frequency, does anyone know where you can find pharmacology on brilacidin? Like half life and metabolism and stuff like that?
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links